Germany · Delayed Price · Currency is EUR FamiCord AG Company Description
FamiCord AG engages in the collection, processing, storage, and distribution of cells, tissues, blood, and blood components for medical applications in Germany, Poland, Switzerland, Portugal, and internationally.
The company operates through Subgroup Vita 34 And Subgroup PBKM segments. It produces and develops advanced therapies, genetic tests, and analyses for third parties.
The company also engages in the development and manufacture of cell and tissue-based products and pharmaceuticals, including the production of viral vectors or comparable products.
In addition, it engages in research and development, storage, and cryopreservation of sperm and oocytes for use in reproductive medicine; and the manufacturing and distribution of medical devices.
The company was formerly known as VITA 34 AG and changed its name to FamiCord AG in February 2025. FamiCord AG was founded in 1997 and is headquartered in Leipzig, Germany.
| Country | Germany |
| Founded | 1997 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 766 |
| CEO | Jakub Baran |
Contact Details
Address: Perlickstrasse 5 Leipzig, 04103 Germany | |
| Phone | 49 341 48792 5500 |
| Website | famicord.com |
Stock Details
| Ticker Symbol | V3V |
| Exchange | Deutsche Börse Xetra |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | DE000A0BL849 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jakub Julian Baran | Chairman of the Management Board and Chief Executive Officer |
| Tomasz Franciszek Baran | Vice President of the Management Board and CMO |
| Thomas Pfaadt | Chief Financial Officer and Member of Management Board |
| Dr. Conelia Wittke-Kothe | CCO and Member of Management Board |
| Santiago Luengo | Managing Director of Secuvita |